financetom
Business
financetom
/
Business
/
Annexon Prices $125 Million Stock Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Annexon Prices $125 Million Stock Offering
Jun 6, 2024 1:12 AM

03:52 AM EDT, 06/06/2024 (MT Newswires) -- Annexon ( ANNX ) said late Wednesday it priced an underwritten public offering of about 13 million common shares at $6.25 per share, and pre-funded warrants to buy 7 million shares at $6.249 per share, for expected gross proceeds of $125 million.

The company granted the underwriters a 30-day option to buy up to an additional about 3 million shares.

The offering is expected to close on Friday.

Price: 6.78, Change: -0.01, Percent Change: -0.15

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
InterContinental Hotels Group's Q3 Global Revenue per Available Room Increases
InterContinental Hotels Group's Q3 Global Revenue per Available Room Increases
Oct 22, 2024
06:27 AM EDT, 10/22/2024 (MT Newswires) -- InterContinental Hotels Group ( IHG ) reported Tuesday a 1.5% increase in Q3 global revenue per available room compared with the same period last year. The Americas saw a 1.7% sales increase, while the EMEA region increased by 4.9%, driven by continued growth in the US. Greater China reported a 10.3% decline due...
goeasy Upsizes, Prices Offering of Senior Unsecured Notes
goeasy Upsizes, Prices Offering of Senior Unsecured Notes
Oct 22, 2024
06:24 AM EDT, 10/22/2024 (MT Newswires) -- goeasy (GSY.TO), a Canadian consumer lender, late on Monday said it has priced US$400 million of 6.875% senior unsecured notes due 2030, up from US$350 million previously, and C$150 million of 6% senior unsecured notes due 2030. The company also expects to enter into a currency swap agreement to fix the foreign currency...
Danaher's Q3 Adjusted Earnings Decline, Revenue Rises; Provides Q4 Revenue Guidance
Danaher's Q3 Adjusted Earnings Decline, Revenue Rises; Provides Q4 Revenue Guidance
Oct 22, 2024
06:24 AM EDT, 10/22/2024 (MT Newswires) -- Danaher ( DHR ) reported Q3 adjusted earnings Tuesday of $1.71 per diluted share, down from $1.72 a year earlier. Analysts polled by Capital IQ expected $1.57. Revenue for the quarter ended Sept. 27 was $5.80 billion compared with $5.62 billion a year earlier. Analysts surveyed by Capital IQ expected $5.59 billion. For...
US FDA declines to approve Camurus' rare hormone disorder drug
US FDA declines to approve Camurus' rare hormone disorder drug
Oct 22, 2024
Oct 22 (Reuters) - The U.S. Food and Drug Administration has declined to approve Camurus' drug for the treatment of a rare hormonal disorder due to deficiencies at a third-party manufacturing facility, the Swedish drugmaker said late Monday. WHY IT'S IMPORTANT The FDA's decision could delay the approval and subsequent launch of the drug, CAM2029, meant to treat patients with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved